Tapewire

NYSE · USD

XYL

Xylem Inc.

Export transactions ↓
Tapewire entity
430
SEC CIK
0001524472
Parsed reports
533

Last 12 months

Inside the activity.

1 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202611
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 04, 2019 Filed Feb 5, 2019 20:55 UTC
Napolitano KennethSenior Vice President
SaleCommon Stock 17,999 $70.17 $1,262,989.83
Disclosure

SEC source: 0001209191-19-007291 · doc4.xml · nonDerivative · entry 2

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,158

F1 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $70.02 to $70.40 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Read SEC document
February 04, 2019 Filed Feb 5, 2019 20:55 UTC
Napolitano KennethSenior Vice President
Exercise / conversionCommon Stock 17,999 $30.03 $540,509.97
Disclosure

SEC source: 0001209191-19-007291 · doc4.xml · nonDerivative · entry 1

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,157

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 21, 2018 Filed Feb 15, 2019 15:31 UTC GiftCommon Stock 4,065 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-010521 · doc5.xml · nonDerivative · entry 2

TAMBAKERAS MARKOS I · CIK 0001012990 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Tambakeras Family Trust

Disclosed balance after: 56,455

F3 · shares: On December 21, 2018, 4,065 shares of Xylem Inc. common stock were gifted from the reporting person's personal brokerage account to the Tambakeras Family Trust, of which the reporting person is the sole beneficiary.

F4 · balance_after: Reflects a transfer of 31,005 shares of Xylem Inc. common stock from the reporting person's personal brokerage account to the Tambakeras Family Trust, of which the reporting person is the sole beneficiary.

Read SEC document
November 02, 2018 Filed Nov 6, 2018 21:43 UTC
Flinton DavidSenior Vice President
Tax withholdingCommon Stock 1,390 $68.02 $94,547.80
Disclosure

SEC source: 0001209191-18-057419 · doc4.xml · nonDerivative · entry 1

Flinton David · CIK 0001654800 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,704

F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on November 2, 2015 under the Xylem 2011 Omnibus Incentive Plan.

F2 · balance_after: Additional shares also accrued through a qualified DRIP.

Read SEC document
November 02, 2018 Filed Nov 6, 2018 21:36 UTC
Sabol Colin RSenior Vice President
Tax withholdingCommon Stock 2,453 $68.02 $166,853.06
Disclosure

SEC source: 0001209191-18-057418 · doc4.xml · nonDerivative · entry 1

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,374

F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on November 2, 2015 under the Xylem 2011 Omnibus Incentive Plan.

Read SEC document
September 19, 2018 Filed Sep 19, 2018 21:31 UTC
Stellato Paul AChief Accounting Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 1,500 $0.00 Strike: $26.60 $0.00
Disclosure

SEC source: 0001209191-18-051669 · doc4.xml · derivative · entry 4

Stellato Paul A · CIK 0001714585 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,898

Underlying: Common Stock · 1,500 shares

Expires 2022-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested and exercisable.

Read SEC document
September 19, 2018 Filed Sep 19, 2018 21:31 UTC
Stellato Paul AChief Accounting Officer
SaleCommon Stock 1,500 $82.00 $123,000.00
Disclosure

SEC source: 0001209191-18-051669 · doc4.xml · nonDerivative · entry 2

Stellato Paul A · CIK 0001714585 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,296

F1 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on August 3, 2018.

Read SEC document
September 19, 2018 Filed Sep 19, 2018 21:31 UTC
Stellato Paul AChief Accounting Officer
Exercise / conversionCommon Stock 1,500 $26.60 $39,900.00
Disclosure

SEC source: 0001209191-18-051669 · doc4.xml · nonDerivative · entry 1

Stellato Paul A · CIK 0001714585 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,796

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 17, 2018 Filed Sep 19, 2018 21:25 UTC
Sabol Colin RSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 4,000 $0.00 Strike: $35.96 $0.00
Disclosure

SEC source: 0001209191-18-051667 · doc4.xml · derivative · entry 8

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,930

Underlying: Common Stock · 4,000 shares

Expires 2025-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: These options are fully vested and exercisable.

Read SEC document
September 17, 2018 Filed Sep 19, 2018 21:25 UTC
Sabol Colin RSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 7,017 $0.00 Strike: $38.76 $0.00
Disclosure

SEC source: 0001209191-18-051667 · doc4.xml · derivative · entry 7

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,017 shares

Expires 2024-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: These options are fully vested and exercisable.

Read SEC document
September 17, 2018 Filed Sep 19, 2018 21:25 UTC
Sabol Colin RSenior Vice President
SaleCommon Stock 2,500 $81.37 $203,425.00
Disclosure

SEC source: 0001209191-18-051667 · doc4.xml · nonDerivative · entry 6

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,827

F4 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on August 17, 2018

F6 · price: This price represents the weighted average price per Share of the Issuer, of sales that were executed at prices ranging from $80.91 to $81.64 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
September 17, 2018 Filed Sep 19, 2018 21:25 UTC
Sabol Colin RSenior Vice President
SaleCommon Stock 3,644 $81.37 $296,512.28
Disclosure

SEC source: 0001209191-18-051667 · doc4.xml · nonDerivative · entry 5

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,327

F4 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on August 17, 2018

F5 · price: This price represents the weighted average price per Share of the Issuer, of sales that were executed at prices ranging from $80.84 to $81.60 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

Read SEC document
September 17, 2018 Filed Sep 19, 2018 21:25 UTC
Sabol Colin RSenior Vice President
SaleCommon Stock 4,000 $81.37 $325,480.00
Disclosure

SEC source: 0001209191-18-051667 · doc4.xml · nonDerivative · entry 4

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,971

F1 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on August 17, 2018.

F3 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $80.87 to $81.64 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Read SEC document
September 17, 2018 Filed Sep 19, 2018 21:25 UTC
Sabol Colin RSenior Vice President
Exercise / conversionCommon Stock 4,000 $35.96 $143,840.00
Disclosure

SEC source: 0001209191-18-051667 · doc4.xml · nonDerivative · entry 3

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,971

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 17, 2018 Filed Sep 19, 2018 21:25 UTC
Sabol Colin RSenior Vice President
SaleCommon Stock 7,017 $81.37 $570,973.29
Disclosure

SEC source: 0001209191-18-051667 · doc4.xml · nonDerivative · entry 2

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,971

F1 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on August 17, 2018.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $80.85 to $81.63 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Read SEC document
September 17, 2018 Filed Sep 19, 2018 21:25 UTC
Sabol Colin RSenior Vice President
Exercise / conversionCommon Stock 7,017 $38.76 $271,978.92
Disclosure

SEC source: 0001209191-18-051667 · doc4.xml · nonDerivative · entry 1

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,988

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 10, 2018 Filed Sep 11, 2018 18:13 UTC
Stellato Paul AChief Accounting Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 2,000 $0.00 Strike: $26.60 $0.00
Disclosure

SEC source: 0001209191-18-050427 · doc4.xml · derivative · entry 5

Stellato Paul A · CIK 0001714585 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,398

Underlying: Common Stock · 2,000 shares

Expires 2022-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

Read SEC document
September 10, 2018 Filed Sep 11, 2018 18:13 UTC
Stellato Paul AChief Accounting Officer
SaleCommon Stock 2,000 $79.00 $158,000.00
Disclosure

SEC source: 0001209191-18-050427 · doc4.xml · nonDerivative · entry 3

Stellato Paul A · CIK 0001714585 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,296

F2 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on August 3, 2018.

Read SEC document
September 10, 2018 Filed Sep 11, 2018 18:13 UTC
Stellato Paul AChief Accounting Officer
Exercise / conversionCommon Stock 2,000 $26.60 $53,200.00
Disclosure

SEC source: 0001209191-18-050427 · doc4.xml · nonDerivative · entry 2

Stellato Paul A · CIK 0001714585 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,296

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 07, 2018 Filed Sep 11, 2018 18:13 UTC
Stellato Paul AChief Accounting Officer
SaleCommon Stock 1,000 $77.89 $77,890.00
Disclosure

SEC source: 0001209191-18-050427 · doc4.xml · nonDerivative · entry 1

Stellato Paul A · CIK 0001714585 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,296

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on August 3, 2018

Read SEC document
September 01, 2018 Filed Sep 5, 2018 18:26 UTC
Stellato Paul AChief Accounting Officer
Tax withholdingCommon Stock 138 $75.66 $10,441.08
Disclosure

SEC source: 0001209191-18-049472 · doc4.xml · nonDerivative · entry 1

Stellato Paul A · CIK 0001714585 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,296

F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on September 1, 2017 under the Xylem 2011 Omnibus Incentive Plan.

Read SEC document
August 08, 2018 Filed Feb 15, 2019 15:31 UTC GiftCommon Stock 6,599 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-010521 · doc5.xml · nonDerivative · entry 1

TAMBAKERAS MARKOS I · CIK 0001012990 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Tambakeras 2018 Grantor Retained Annuity Trust

Disclosed balance after: 6,620

F1 · shares: On August 8, 2018, 6,599 shares of Xylem Inc. common stock were transferred from the reporting person's family trust to the reporting person's 2018 Grantor Retained Annuity Trust account.

F2 · balance_after: An additional 20 shares accrued through a qualified DRIP.

Read SEC document
August 07, 2018 Filed Aug 7, 2018 14:51 UTC SaleCommon Stock 6,177 $76.48 $472,416.96
Disclosure

SEC source: 0001209191-18-045649 · doc4.xml · nonDerivative · entry 2

CRAWFORD CURTIS J · CIK 0001014318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,244

F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $76.37 to $76.53 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Read SEC document
August 03, 2018 Filed Aug 7, 2018 14:51 UTC SaleCommon Stock 1,323 $75.25 $99,555.75
Disclosure

SEC source: 0001209191-18-045649 · doc4.xml · nonDerivative · entry 1

CRAWFORD CURTIS J · CIK 0001014318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,421

F1 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $75.24 to $75.3 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Read SEC document
August 03, 2018 Filed Aug 7, 2018 14:53 UTC
Tarapore KairusSVP & CHRO
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 16,500 $0.00 Strike: $33.85 $0.00
Disclosure

SEC source: 0001209191-18-045650 · doc4.xml · derivative · entry 5

Tarapore Kairus · CIK 0001383582 · SVP & CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,138

Underlying: Common Stock · 16,500 shares

Expires 2025-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options are fully vested and exercisable.

Read SEC document
August 03, 2018 Filed Aug 7, 2018 14:53 UTC
Tarapore KairusSVP & CHRO
Tax withholdingCommon Stock 1,048 $76.00 $79,648.00
Disclosure

SEC source: 0001209191-18-045650 · doc4.xml · nonDerivative · entry 4

Tarapore Kairus · CIK 0001383582 · SVP & CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,732

Read SEC document
August 03, 2018 Filed Aug 7, 2018 14:53 UTC
Tarapore KairusSVP & CHRO
SaleCommon Stock 2,300 $75.17 $172,891.00
Disclosure

SEC source: 0001209191-18-045650 · doc4.xml · nonDerivative · entry 3

Tarapore Kairus · CIK 0001383582 · SVP & CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,780

Read SEC document
August 03, 2018 Filed Aug 7, 2018 14:53 UTC
Tarapore KairusSVP & CHRO
SaleCommon Stock 16,500 $75.17 $1,240,305.00
Disclosure

SEC source: 0001209191-18-045650 · doc4.xml · nonDerivative · entry 2

Tarapore Kairus · CIK 0001383582 · SVP & CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,080

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $75.10 to $75.27 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Read SEC document
August 03, 2018 Filed Aug 7, 2018 14:53 UTC
Tarapore KairusSVP & CHRO
Exercise / conversionCommon Stock 16,500 $33.85 $558,525.00
Disclosure

SEC source: 0001209191-18-045650 · doc4.xml · nonDerivative · entry 1

Tarapore Kairus · CIK 0001383582 · SVP & CHRO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,580

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 14, 2018 Filed May 15, 2018 09:41 UTC SaleCommon Stock 7,500 $73.39 $550,395.00
Disclosure

SEC source: 0001209191-18-030102 · doc4.xml · nonDerivative · entry 1

CRAWFORD CURTIS J · CIK 0001014318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,744

F1 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $73.32 to $73.46 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Read SEC document
May 09, 2018 Filed May 10, 2018 12:55 UTC GrantCommon Stock 2,886 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029121 · doc4.xml · nonDerivative · entry 1

TAMBAKERAS MARKOS I · CIK 0001012990 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,956

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2019 annual shareholders' meeting.

Read SEC document
May 09, 2018 Filed May 10, 2018 13:04 UTC GrantCommon Stock 1,947 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029124 · doc4.xml · nonDerivative · entry 1

CRAWFORD CURTIS J · CIK 0001014318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,244

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2019 annual shareholders' meeting.

Read SEC document
May 09, 2018 Filed May 10, 2018 16:45 UTC GrantCommon Stock 1,947 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029115 · doc4.xml · nonDerivative · entry 1

Peribere Jerome A · CIK 0001484527 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,555

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2019 annual shareholders' meeting.

F2 · balance_after: Additional shares also accrued through a qualified DRIP.

Read SEC document
May 09, 2018 Filed May 10, 2018 17:02 UTC GrantCommon Stock 1,947 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029123 · doc4.xml · nonDerivative · entry 1

Harker Victoria D · CIK 0001350579 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,551

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2019 annual shareholders' meeting.

Read SEC document
May 09, 2018 Filed May 10, 2018 16:48 UTC GrantCommon Stock 1,947 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029118 · doc4.xml · nonDerivative · entry 1

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,078

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2019 annual shareholders' meeting.

Read SEC document
May 09, 2018 Filed May 10, 2018 16:46 UTC GrantCommon Stock 1,947 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029116 · doc4.xml · nonDerivative · entry 1

FRIEL ROBERT F · CIK 0001224110 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,805

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2019 annual shareholders' meeting.

F2 · balance_after: Additional shares also accrued through a qualified DRIP.

Read SEC document
May 09, 2018 Filed May 10, 2018 12:58 UTC GrantCommon Stock 1,947 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029122 · doc4.xml · nonDerivative · entry 1

MOHAPATRA SURYA N · CIK 0001222671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,416

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2019 annual shareholders' meeting.

Read SEC document
May 09, 2018 Filed May 10, 2018 16:53 UTC GrantCommon Stock 1,947 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029120 · doc4.xml · nonDerivative · entry 1

Beliveau-Dunn Jeanne · CIK 0001714894 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,699

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2019 annual shareholders' meeting.

Read SEC document
May 09, 2018 Filed May 10, 2018 16:49 UTC GrantCommon Stock 1,947 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-029119 · doc4.xml · nonDerivative · entry 2

Jakobsson Sten E · CIK 0001532863 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,775

F2 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2019 annual shareholder's meeting.

Read SEC document
May 08, 2018 Filed May 10, 2018 16:49 UTC Tax withholdingCommon Stock 338 $70.85 $23,947.30
Disclosure

SEC source: 0001209191-18-029119 · doc4.xml · nonDerivative · entry 1

Jakobsson Sten E · CIK 0001532863 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,828

F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incidental to the vesting of stock-settled restricted stock units.

Read SEC document
May 07, 2018 Filed May 8, 2018 19:24 UTC Tax withholdingCommon Stock 646 $70.02 $45,232.92
Disclosure

SEC source: 0001209191-18-028520 · doc4.xml · nonDerivative · entry 1

RAJKOWSKI E MARK · CIK 0001258268 · SVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,715

F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 5, 2016 under the Xylem 2011 Omnibus Incentive Plan.

F2 · balance_after: Additional shares also accrued through a qualified DRIP.

Read SEC document
March 05, 2018 Filed Mar 6, 2018 20:13 UTC
Brannemo TomasSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 3,913 $0.00 Strike: $48.33 $0.00
Disclosure

SEC source: 0001209191-18-017154 · doc4.xml · derivative · entry 10

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,824

Underlying: Common Stock · 3,913 shares

Expires 2027-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options vest in 3 equal annual installments beginning on February 21, 2018.

Read SEC document
March 05, 2018 Filed Mar 6, 2018 20:13 UTC
Brannemo TomasSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 2,772 $0.00 Strike: $37.47 $0.00
Disclosure

SEC source: 0001209191-18-017154 · doc4.xml · derivative · entry 9

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,771

Underlying: Common Stock · 2,772 shares

Expires 2026-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options vest in 3 equal annual installments beginning on February 24, 2017.

Read SEC document
March 05, 2018 Filed Mar 6, 2018 20:13 UTC
Brannemo TomasSenior Vice President
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 3,986 $0.00 Strike: $35.96 $0.00
Disclosure

SEC source: 0001209191-18-017154 · doc4.xml · derivative · entry 8

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,986 shares

Expires 2025-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options are fully vested and exercisable.

Read SEC document
March 05, 2018 Filed Mar 6, 2018 20:13 UTC
Brannemo TomasSenior Vice President
SaleCommon Stock 1,045 $73.47 $76,776.15
Disclosure

SEC source: 0001209191-18-017154 · doc4.xml · nonDerivative · entry 7

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,817

Read SEC document
March 05, 2018 Filed Mar 6, 2018 20:13 UTC
Brannemo TomasSenior Vice President
SaleCommon Stock 3,913 $73.45 $287,409.85
Disclosure

SEC source: 0001209191-18-017154 · doc4.xml · nonDerivative · entry 6

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,862

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $73.44 to $73.52 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Read SEC document
March 05, 2018 Filed Mar 6, 2018 20:13 UTC
Brannemo TomasSenior Vice President
Exercise / conversionCommon Stock 3,913 $48.33 $189,115.29
Disclosure

SEC source: 0001209191-18-017154 · doc4.xml · nonDerivative · entry 5

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,775

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 05, 2018 Filed Mar 6, 2018 20:13 UTC
Brannemo TomasSenior Vice President
SaleCommon Stock 2,772 $73.45 $203,603.40
Disclosure

SEC source: 0001209191-18-017154 · doc4.xml · nonDerivative · entry 4

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,862

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $73.44 to $73.52 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Read SEC document
March 05, 2018 Filed Mar 6, 2018 20:13 UTC
Brannemo TomasSenior Vice President
Exercise / conversionCommon Stock 2,772 $37.47 $103,866.84
Disclosure

SEC source: 0001209191-18-017154 · doc4.xml · nonDerivative · entry 3

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,634

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 05, 2018 Filed Mar 6, 2018 20:13 UTC
Brannemo TomasSenior Vice President
SaleCommon Stock 3,986 $73.45 $292,771.70
Disclosure

SEC source: 0001209191-18-017154 · doc4.xml · nonDerivative · entry 2

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,862

F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $73.44 to $73.52 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.